News
IBXNF
1.000
NaN%
--
Weekly Report: what happened at IBXNF last week (0401-0405)?
Weekly Report · 04/08 09:46
Weekly Report: what happened at IBXNF last week (0325-0329)?
Weekly Report · 04/01 09:46
Weekly Report: what happened at IBXNF last week (0318-0322)?
Weekly Report · 03/25 09:47
IBEX Technologies GAAP EPS of C$0.03, revenue of C$3.98M
Seeking Alpha · 03/22 20:44
Weekly Report: what happened at IBXNF last week (0311-0315)?
Weekly Report · 03/18 09:46
Weekly Report: what happened at IBXNF last week (0304-0308)?
Weekly Report · 03/11 09:45
Weekly Report: what happened at IBXNF last week (0226-0301)?
Weekly Report · 03/04 09:46
Weekly Report: what happened at IBXNF last week (0219-0223)?
Weekly Report · 02/26 09:51
IBEX Files Management Proxy Circular for Sale of the Company at $1.45 Per Share
Barchart · 02/23 14:10
Weekly Report: what happened at IBXNF last week (0212-0216)?
Weekly Report · 02/19 09:51
IBEX Technologies signs definitive agreement for sale of the company
IBEX Technologies signs definitive agreement for sale of the company. The total consideration is $37.9M. IBEX Technologies will be exchanged for $1.45/share in cash. The company has entered into a binding acquisition agreement with a subsidiary of BBI Solutions.
Seeking Alpha · 02/12 12:47
Weekly Report: what happened at IBXNF last week (0205-0209)?
Weekly Report · 02/12 09:47
Weekly Report: what happened at IBXNF last week (0129-0202)?
Weekly Report · 02/05 09:50
Weekly Report: what happened at IBXNF last week (0122-0126)?
Weekly Report · 01/29 09:47
Weekly Report: what happened at IBXNF last week (0115-0119)?
Weekly Report · 01/22 09:48
Weekly Report: what happened at IBXNF last week (0108-0112)?
Weekly Report · 01/15 09:47
Weekly Report: what happened at IBXNF last week (0101-0105)?
Weekly Report · 01/08 09:48
Weekly Report: what happened at IBXNF last week (1225-1229)?
Weekly Report · 01/01 09:46
Weekly Report: what happened at IBXNF last week (1218-1222)?
Weekly Report · 12/25/2023 09:50
Weekly Report: what happened at IBXNF last week (1211-1215)?
Weekly Report · 12/18/2023 09:53
More
Webull provides a variety of real-time IBXNF stock news. You can receive the latest news about Ibex Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About IBXNF
IBEX Technologies Inc., through its subsidiaries, IBEX Pharmaceuticals Inc. and BioResearch Products Inc., manufactures and markets enzymes for biomedical use. The Company also manufactures and markets a series of arthritis assays, which enable the study of both the synthesis and degradation of cartilage components. It operates through the production and sale of diagnostic products segment. Its products include IB-C2C-HUSA, C2C Assay, CPII Assay, C1-2C Assay and CS-846 Assay. It provides various individual collagen associated antibodies, such as Ab1320-Rabbit Polyclonal Antibody; Type IX Collagen Antibody, and C1-2C Antibody (Col 2 3/4C short Antibody). Its diagnostic microtiter enzyme-linked immunosorbent assays include C2C-Collagen Type II Cleavage Assay; IB-C2C-HUSA-IBEX C2C Human Urine Sandwich Assay; C1,2C-Collagen Type I and II Cleavage Assay (Col 2 3/4C short antibody); CPII-Procollagen Type II C-Propeptide Assay, and CS846-Aggrecan Chondroitin Sulfate 846 Epitope Assay.